1. Clinical testing of three novel transient receptor potential cation channel subfamily V member 1 antagonists in a pharmacodynamic intradermal capsaicin model. (10th April 2018) Authors: Sjögren, E.; Kullenberg, T.; Jonzon, B.; Segerdahl, M.; Stålberg, O.; Halldin, M.M.; Sundgren‐Andersson, A.K. Journal: European journal of pain Issue: Volume 22:Number 7(2018) Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0494 Steroid-Sparing Effect of Anakinra (Kineret®) in the Treatment of Patients with Severe Cryopyrin-Associated Periodic Syndromes. (9th June 2015) Authors: Kullenberg, T.; Hallén, B.; Olivecrona, H.; Leinonen, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0485 Safety Profile of the IL-1 Receptor Antagonist Kineret® (Anakinra) in a Long-Term Outcome Study in Patients with Severe Cryopyrin-Associated Periodic Syndromes (Caps). (23rd January 2014) Authors: Kullenberg, T.; Löfqvist, M.; Olivecrona, H.; Plass, N.; Kost, B.; Sibley, C.; Goldbach-Mansky, R. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0409 A RANDOMIZED, PHASE 2 STUDY EVALUATING THE EFFICACY AND SAFETY OF ANAKINRA IN DIFFICULT-TO-TREAT ACUTE GOUTY ARTHRITIS: THE ANAGO STUDY. (2nd June 2020) Authors: Saag, K.; So, A.; Khanna, P.; Keenan, R.; Ohlman, S.; Kullenberg, T.; Osterling Koskinen, L.; Pillinger, M. H.; Terkeltaub, R. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗